Literature DB >> 25320007

Nuclear factor of activated T-cell activity is associated with metastatic capacity in colon cancer.

Manish K Tripathi1, Natasha G Deane2, Jing Zhu3, Hanbing An1, Shinji Mima1, Xiaojing Wang3, Sekhar Padmanabhan1, Zhiao Shi4, Naresh Prodduturi3, Kristen K Ciombor5, Xi Chen6, M Kay Washington7, Bing Zhang8, R Daniel Beauchamp9.   

Abstract

Metastatic recurrence is the leading cause of cancer-related deaths in patients with colorectal carcinoma. To capture the molecular underpinnings for metastasis and tumor progression, we performed integrative network analysis on 11 independent human colorectal cancer gene expression datasets and applied expression data from an immunocompetent mouse model of metastasis as an additional filter for this biologic process. In silico analysis of one metastasis-related coexpression module predicted nuclear factor of activated T-cell (NFAT) transcription factors as potential regulators for the module. Cells selected for invasiveness and metastatic capability expressed higher levels of NFATc1 as compared with poorly metastatic and less invasive parental cells. We found that inhibition of NFATc1 in human and mouse colon cancer cells resulted in decreased invasiveness in culture and downregulation of metastasis-related network genes. Overexpression of NFATc1 significantly increased the metastatic potential of colon cancer cells, whereas inhibition of NFATc1 reduced metastasis growth in an immunocompetent mouse model. Finally, we found that an 8-gene signature comprising genes upregulated by NFATc1 significantly correlated with worse clinical outcomes in stage II and III colorectal cancer patients. Thus, NFATc1 regulates colon cancer cell behavior and its transcriptional targets constitute a novel, biologically anchored gene expression signature for the identification of colon cancers with high risk of metastatic recurrence. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25320007      PMCID: PMC4252979          DOI: 10.1158/0008-5472.CAN-14-1592

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

Review 1.  Network biology: understanding the cell's functional organization.

Authors:  Albert-László Barabási; Zoltán N Oltvai
Journal:  Nat Rev Genet       Date:  2004-02       Impact factor: 53.242

Review 2.  NFAT proteins: key regulators of T-cell development and function.

Authors:  Fernando Macian
Journal:  Nat Rev Immunol       Date:  2005-06       Impact factor: 53.106

Review 3.  Transcriptional regulation by calcium, calcineurin, and NFAT.

Authors:  Patrick G Hogan; Lin Chen; Julie Nardone; Anjana Rao
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

4.  Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.

Authors:  Tanner J Freeman; J Joshua Smith; Xi Chen; M Kay Washington; Joseph T Roland; Anna L Means; Steven A Eschrich; Timothy J Yeatman; Natasha G Deane; R Daniel Beauchamp
Journal:  Gastroenterology       Date:  2011-11-22       Impact factor: 22.682

5.  Barriers to Integrating Gene Profiling for Stage II Colon Cancer.

Authors:  Scott Kopetz; James L Abbruzzese
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

6.  Prognostic gene expression signature associated with two molecularly distinct subtypes of colorectal cancer.

Authors:  Sang Cheul Oh; Yun-Yong Park; Eun Sung Park; Jae Yun Lim; Soo Mi Kim; Sang-Bae Kim; Jongseung Kim; Sang Cheol Kim; In-Sun Chu; J Joshua Smith; R Daniel Beauchamp; Timothy J Yeatman; Scott Kopetz; Ju-Seog Lee
Journal:  Gut       Date:  2011-10-13       Impact factor: 23.059

7.  Sequential activation of NFAT and c-Myc transcription factors mediates the TGF-beta switch from a suppressor to a promoter of cancer cell proliferation.

Authors:  Garima Singh; Shiv K Singh; Alexander König; Kristina Reutlinger; Monica D Nye; Tillman Adhikary; Martin Eilers; Thomas M Gress; Martin E Fernandez-Zapico; Volker Ellenrieder
Journal:  J Biol Chem       Date:  2010-06-01       Impact factor: 5.157

8.  NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells.

Authors:  Alexander Köenig; Thomas Linhart; Katrin Schlengemann; Kristina Reutlinger; Jessica Wegele; Guido Adler; Garima Singh; Leonie Hofmann; Steffen Kunsch; Thomas Büch; Eva Schäfer; Thomas M Gress; Martin E Fernandez-Zapico; Volker Ellenrieder
Journal:  Gastroenterology       Date:  2009-11-06       Impact factor: 22.682

9.  Co-expression module analysis reveals biological processes, genomic gain, and regulatory mechanisms associated with breast cancer progression.

Authors:  Zhiao Shi; Catherine K Derow; Bing Zhang
Journal:  BMC Syst Biol       Date:  2010-05-27

10.  A map of human protein interactions derived from co-expression of human mRNAs and their orthologs.

Authors:  Arun K Ramani; Zhihua Li; G Traver Hart; Mark W Carlson; Daniel R Boutz; Edward M Marcotte
Journal:  Mol Syst Biol       Date:  2008-04-15       Impact factor: 11.429

View more
  40 in total

1.  NFAT2 Isoforms Differentially Regulate Gene Expression, Cell Death, and Transformation through Alternative N-Terminal Domains.

Authors:  Pedro I Lucena; Douglas V Faget; Emilia Pachulec; Marcela C Robaina; Claudete E Klumb; Bruno K Robbs; João P B Viola
Journal:  Mol Cell Biol       Date:  2015-10-19       Impact factor: 4.272

2.  The Osteogenic Niche Is a Calcium Reservoir of Bone Micrometastases and Confers Unexpected Therapeutic Vulnerability.

Authors:  Hai Wang; Lin Tian; Jun Liu; Amit Goldstein; Igor Bado; Weijie Zhang; Benjamin R Arenkiel; Zonghai Li; Meng Yang; Shiyu Du; Hong Zhao; David R Rowley; Stephen T C Wong; Zbigniew Gugala; Xiang H-F Zhang
Journal:  Cancer Cell       Date:  2018-11-12       Impact factor: 31.743

Review 3.  Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications.

Authors:  Hui Xu; Lei Liu; Weilin Li; Duowu Zou; Jun Yu; Lifu Wang; Chi Chun Wong
Journal:  Oncogene       Date:  2020-12-15       Impact factor: 9.867

4.  Smoking is associated with hypermethylation of the APC 1A promoter in colorectal cancer: the ColoCare Study.

Authors:  Timothy M Barrow; Hagen Klett; Reka Toth; Jürgen Böhm; Biljana Gigic; Nina Habermann; Dominique Scherer; Petra Schrotz-King; Stephanie Skender; Clare Abbenhardt-Martin; Lin Zielske; Martin Schneider; Alexis Ulrich; Peter Schirmacher; Esther Herpel; Hermann Brenner; Hauke Busch; Melanie Boerries; Cornelia M Ulrich; Karin B Michels
Journal:  J Pathol       Date:  2017-09-29       Impact factor: 7.996

5.  Establishment and verification of a prognostic tumor microenvironment-based and immune-related gene signature in colon cancer.

Authors:  Tianyu Guo; Zhe Wang; Yefu Liu
Journal:  J Gastrointest Oncol       Date:  2021-10

6.  Construction of a New Tumor Immunity-Related Signature to Assess and Classify the Prognostic Risk of Colorectal Cancer.

Authors:  Xiaocheng Wu; Tianxing Yang; Liping Qian; Desheng Zhang; Hui Yang
Journal:  Int J Gen Med       Date:  2021-10-12

7.  Hidden patterns of gene expression provide prognostic insight for colorectal cancer.

Authors:  Dongsan Kim; Kwang-Hyun Cho
Journal:  Cancer Gene Ther       Date:  2022-08-18       Impact factor: 5.854

8.  The MAPK Pathway Regulates Intrinsic Resistance to BET Inhibitors in Colorectal Cancer.

Authors:  Yufang Ma; Lihong Wang; Leif R Neitzel; Sudan N Loganathan; Nan Tang; Lili Qin; Emily E Crispi; Yan Guo; Stefan Knapp; R Daniel Beauchamp; Ethan Lee; Jialiang Wang
Journal:  Clin Cancer Res       Date:  2016-09-27       Impact factor: 12.531

9.  MethReg: estimating the regulatory potential of DNA methylation in gene transcription.

Authors:  Tiago C Silva; Juan I Young; Eden R Martin; X Steven Chen; Lily Wang
Journal:  Nucleic Acids Res       Date:  2022-05-20       Impact factor: 19.160

Review 10.  Cell cycle and apoptosis regulation by NFAT transcription factors: new roles for an old player.

Authors:  G P Mognol; F R G Carneiro; B K Robbs; D V Faget; J P B Viola
Journal:  Cell Death Dis       Date:  2016-04-21       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.